BofAS: China's CXO Sector Benefiting From Strong Biotech Financing, Raises TPs for WUXI APPTEC and OthersAASTOCKS News·Aug 11 at 10:36 PMWXXWY+0.57%02359-1.56%
Nomura Raises PHARMARON TP to HKD32.2 on Higher FY Revenue Forecast Driven by Order BacklogAASTOCKS News·Jul 27 at 02:12 AM03759-2.66%300759-5.28%
Pharmaron Unveils 2026 H Share Incentive Plan and Governance OverhaulTip Ranks·Jul 24 at 06:09 AM03759-2.66%300759-5.28%
Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issuedPUBT·Jul 22 at 03:40 AM03759-2.66%300759-5.28%
HSBC Research Keeps PHARMARON at Buy, Expects Strong CDMO Growth to Offset FX PressureAASTOCKS News·Jul 15 at 09:40 PM300759-5.28%03759-2.66%
Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)Tip Ranks·Jul 15 at 07:26 PM300759-5.28%03759-2.66%
